Back to Search
MARK HOLLINGSHEAD, M.D.
M.D.
Ophthalmology Physician
NPI: 1689670911Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
M6436(ID)
Research & Publications (20)
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
PMID 19232100·BMC Cancer·2009
7-preclinical
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction.
PMID 19533749·Int J Cancer·2009
8-other
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
PMID 19584228·Mol Cancer Ther·2009
7-preclinical
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
PMID 19084416·Bioorg Med Chem·2009
7-preclinical
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
PMID 19636271·J Pediatr Hematol Oncol·2009
7-preclinical
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.
PMID 19175523·Pigment Cell Melanoma Res·2009
7-preclinical
Acute necrotizing encephalopathy of childhood: typical findings in an atypical disease.
PMID 18415059·Pediatr Radiol·2008
5-case
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
PMID 18394172·Mol Cancer·2008
7-preclinical
Preclinical modeling of a phase 0 clinical trial: qualification of a pharmacodynamic assay of poly (ADP-ribose) polymerase in tumor biopsies of mouse xenografts.
PMID 18980982·Clin Cancer Res·2008
7-preclinical
CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.
PMID 18854445·AJNR Am J Neuroradiol·2008
5-case
Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
PMID 18199555·Cancer Res·2008
7-preclinical
Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.
PMID 17722994·Radiat Res·2007
7-preclinical
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
PMID 17404101·Clin Cancer Res·2007
7-preclinical
Proteomic analysis identifies oxidative stress induction by adaphostin.
PMID 17575232·Clin Cancer Res·2007
8-other
Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms.
PMID 17631503·J Biol Chem·2007
7-preclinical
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
PMID 18199854·Mol Interv·2007
6-review
Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.
PMID 17034134·J Med Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 360 E MALLARD DR, SUITE 125
BOISE, ID 83706 - Phone
- (208) 336-8700
Quick Facts
- NPI
- 1689670911
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile